Cyclerion Therapeutics, Inc. (CYCN)
↓ Download CSV- Sector Manufacturing
- Incorporated MA
- Fiscal year ends Dec 31
In fiscal 2025, Cyclerion Therapeutics, Inc. reported revenue of $2.07M, up 3.7% from the prior year. The company ran a net loss, with a net margin of -170.1%.
Key ratios (FY2025)
-239.8%
Operating margin
-170.1%
Net margin
-38.8%
Return on equity
+3.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.07M | $2.00M | $0 | $297.0K | $3.94M | $2.30M | — | — | — |
| Operating Income | -$4.97M | -$3.63M | -$12.95M | -$18.54M | -$55.20M | -$81.27M | -$125.04M | -$115.25M | — |
| Net Income | -$3.53M | -$3.06M | -$5.26M | -$44.08M | -$51.65M | -$77.80M | -$123.01M | -$115.25M | — |
| EPS (Diluted) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | — | — | — | — |
| Total Assets | $9.98M | $9.57M | $13.37M | $18.08M | $59.33M | $115.38M | $186.48M | $7.40M | — |
| Shareholders' Equity | $9.09M | $8.85M | $11.29M | $10.45M | $48.25M | $59.49M | $97.73M | -$10.45M | -$8.57M |
| Cash & Equivalents | $3.24M | $3.23M | $7.57M | $13.38M | $53.96M | $54.40M | $94.89M | — | — |
| Operating Cash Flow | -$3.31M | -$4.33M | -$21.25M | -$40.61M | -$36.52M | -$72.49M | -$102.22M | -$97.50M | — |
| Capital Expenditures | — | — | — | $0 | $7.0K | $1.52M | $6.89M | $3.44M | — |
| Shares Outstanding | 3.82M | 2.55M | 2.47M | 2.18M | 43.41M | 34.05M | 27.60M | 0 | — |